Discover more insights into Refractory Pediatric 难治性儿科

Keywords frequently search together with Refractory Pediatric 难治性儿科

Narrow sentence examples with built-in keyword filters

Refractory Pediatric sentence examples within Treat Refractory Pediatric



P382 High anti-tumor necrosis factor alpha treatment trough concentrations are not associated with higher rate of adverse events in pediatric patients with inflammatory bowel disease


High anti-TNFα Concentrations are Not Associated With More Adverse Events in Pediatric Inflammatory Bowel Disease.

Refractory Pediatric sentence examples within Otherwise Refractory Pediatric



Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection


Case Series: Refractory Cases of Hyper-serum IgE Achieve Transformative Decrease by TCM Therapy

Refractory Pediatric sentence examples within refractory pediatric cancer



Combination therapy with anti-PD-1 or PD-1 antibody alone in pediatric patients with relapsed or refractory cancer.


Combination Therapy With Anti-PD-1 or PD-1 Antibody Alone in Asian Pediatric Patients With Relapsed or Refractory Cancer


Learn more from Refractory Pediatric 难治性儿科


Refractory Pediatric sentence examples within refractory pediatric epilepsy



Spatiotemporal distribution and age of seizure onset in a pediatric epilepsy surgery cohort with cortical dysplasia


Intravenous ketogenic diet: guidelines for ketogenic parenteral therapy

Refractory Pediatric sentence examples within refractory pediatric solid



Influence of UGT1A1 *6/*28 Polymorphisms on Irinotecan-Related Toxicity and Survival in Pediatric Patients with Relapsed/Refractory Solid Tumors Treated with the VIT Regimen


Cytotoxicity and Target Modulation in Pediatric Solid Tumors by the Proteasome Inhibitor Carfilzomib.

Refractory Pediatric sentence examples within refractory pediatric b



Improving CAR T cell immunotherapy-mediated remissions for pediatric leukemia.


Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR

Refractory Pediatric sentence examples within refractory pediatric leukemium



Preclinical evaluation of the ETS inhibitor TK216 against relapsed and refractory childhood leukemia.


Targeted Polo-like Kinase Inhibition Combined With Aurora Kinase Inhibition in Pediatric Acute Leukemia Cells

Refractory Pediatric sentence examples within refractory pediatric psoriasi



Refractory Pediatric Psoriasis and Atopic Dermatitis: The Importance of Therapeutical Adherence and Biological Management


Success of the IL-17 Inhibitor Ixekizumab in a Case of Refractory Pediatric Psoriasis and a Summary of FDA-Approved Biologics for Moderate to Severe Pediatric Psoriasis Vulgaris

Refractory Pediatric sentence examples within refractory pediatric inflammatory



P382 High anti-tumor necrosis factor alpha treatment trough concentrations are not associated with higher rate of adverse events in pediatric patients with inflammatory bowel disease


High anti-TNFα Concentrations are Not Associated With More Adverse Events in Pediatric Inflammatory Bowel Disease.

Refractory Pediatric sentence examples within refractory pediatric statu



Levetiracetam Versus Phenytoin or Fosphenytoin for Second-Line Treatment of Pediatric Status Epilepticus: A Meta-Analysis


Noninvasive Ventilation Use in Pediatric Status Asthmaticus.

Refractory Pediatric sentence examples within refractory pediatric wilm



Irinotecan Plus Doxorubicin Hydrochloride Liposomes for Relapsed or Refractory Wilms Tumor


The efficacy and safety of irinotecan plus doxorubicin liposome in relapsed/refractory Wilms’ tumors: A retrospective study.


Combination therapy with anti-PD-1 or PD-1 antibody alone in pediatric patients with relapsed or refractory cancer.



Combination Therapy With Anti-PD-1 or PD-1 Antibody Alone in Asian Pediatric Patients With Relapsed or Refractory Cancer



P382 High anti-tumor necrosis factor alpha treatment trough concentrations are not associated with higher rate of adverse events in pediatric patients with inflammatory bowel disease



Preclinical evaluation of the ETS inhibitor TK216 against relapsed and refractory childhood leukemia.



Treatment of Relapsed and Refractory ALK-Positive Anaplastic Large Cell Lymphoma With ALK-Specific Tyrosine Kinase Inhibitor in Children: A Case Series.



Influence of UGT1A1 *6/*28 Polymorphisms on Irinotecan-Related Toxicity and Survival in Pediatric Patients with Relapsed/Refractory Solid Tumors Treated with the VIT Regimen



Single-Agent Oral Vinorelbine in the Treatment of Pediatric Progressive Optic Pathway Glioma: A Single Institutional Experience



Low-Dose Ketamine Infusion for Pediatric Hematology/Oncology Patients: Case Series and Literature Review.



Levetiracetam Versus Phenytoin or Fosphenytoin for Second-Line Treatment of Pediatric Status Epilepticus: A Meta-Analysis



Tofacitinib Therapy in Children and Young Adults With Pediatric-onset Medically Refractory Inflammatory Bowel Disease



Association Between Intravenous Magnesium Therapy in the Emergency Department and Subsequent Hospitalization Among Pediatric Patients With Refractory Acute Asthma: Secondary Analysis of a Randomized Clinical Trial.



Progress Update in Pediatric Renal Tumors



Irinotecan Plus Doxorubicin Hydrochloride Liposomes for Relapsed or Refractory Wilms Tumor



Abstract 642: Genomes for Kids: Comprehensive DNA and RNA sequencing defining the scope of actionable mutations in pediatric cancer



The efficacy and safety of irinotecan plus doxorubicin liposome in relapsed/refractory Wilms’ tumors: A retrospective study.



Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection



Noninvasive Ventilation Use in Pediatric Status Asthmaticus.



Refractory Pediatric Psoriasis and Atopic Dermatitis: The Importance of Therapeutical Adherence and Biological Management



Case Series: Refractory Cases of Hyper-serum IgE Achieve Transformative Decrease by TCM Therapy



Factors impacting enrollment on NCI-COG Pediatric MATCH trial treatment protocols.



Targeting pediatric leukemia propagating cells using anti-CD200 antibody therapy.



Sirolimus Pharmacokinetics Variability Points to the Relevance of Therapeutic Drug Monitoring in Pediatric Oncology



Refractory Extracutaneous Juvenile Xanthogranuloma With Multiple Intracranial Nodular Lesions Successfully Treated With 2-Chlorodeoxyadenosine.



High anti-TNFα Concentrations are Not Associated With More Adverse Events in Pediatric Inflammatory Bowel Disease.



Spatiotemporal distribution and age of seizure onset in a pediatric epilepsy surgery cohort with cortical dysplasia



Cytotoxicity and Target Modulation in Pediatric Solid Tumors by the Proteasome Inhibitor Carfilzomib.



Genomes for Kids: The scope of pathogenic mutations in pediatric cancer revealed by comprehensive DNA and RNA sequencing.



Improving CAR T cell immunotherapy-mediated remissions for pediatric leukemia.



Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR



Intravenous ketogenic diet: guidelines for ketogenic parenteral therapy



Nivolumab in the Treatment of Recurrent or Refractory Pediatric Brain Tumors: A Single Institutional Experience


More Refractory Pediatric 难治性儿科 sentence examples
10.1158/2326-6074.CRICIMTEATIAACR18-A001

Abstract A001: Phase I study of vaccine therapy with a cocktail of peptides for pediatric patients with refractory solid tumors



CD9 blockade suppresses disease progression of high-risk pediatric B-cell precursor acute lymphoblastic leukemia and enhances chemosensitivity



Population pharmacokinetics, exposure-safety, and immunogenicity of atezolizumab in pediatric and young adult patients with cancer



Prospective evaluation of oral cannabis extracts in children with epilepsy



Targeted Polo-like Kinase Inhibition Combined With Aurora Kinase Inhibition in Pediatric Acute Leukemia Cells



Contribution of Altered Endocannabinoid System to Overactive mTORC1 Signaling in Focal Cortical Dysplasia



Cosyntropin for the Treatment of Refractory Postdural Puncture Headache in Pediatric Patients



CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors



Abstract CT112: A Phase I multicenter trial of the dual MDM2/MDMX inhibitor ALRN-6924 in children and young adults with relapsed/refractory pediatric cancers



From Resection to Disconnection for Seizure Control in Pediatric Epilepsy Children



Success of the IL-17 Inhibitor Ixekizumab in a Case of Refractory Pediatric Psoriasis and a Summary of FDA-Approved Biologics for Moderate to Severe Pediatric Psoriasis Vulgaris



A monthly roundup of key articles in other journals



XEN-augmented Baerveldt Implantation for Refractory Childhood Glaucoma: A Retrospective Case Series



Cost-Effectiveness of Treatment Alternatives for Treatment-Refractory Pediatric Obsessive-Compulsive Disorder.



Current approaches in the grading and management of cytokine release syndrome after chimeric antigen receptor T-cell therapy



Discovery of actionable genetic alterations with targeted panel sequencing in children with relapsed or refractory solid tumors



Surgical management of medically-refractory hyperinsulinism.



Reliability and safety of Etomidate speech test in children with drug resistant focal epilepsy



Treatment of children with relapsed and refractory acute lymphoblastic leukemia with mitoxantrone, vincristine, pegaspargase, dexamethasone, and bortezomib



Efficacy of the NCCV Cocktail‐1 vaccine for refractory pediatric solid tumors: A phase I clinical trial



Enhancing Outpatient Dihydroergotamine Infusion With Interdisciplinary Care to Treat Refractory Pediatric Migraine: Preliminary Outcomes From the Comprehensive Aggressive Migraine Protocol (“CAMP”)


Refractory Pediatric 难治性儿科


Refractory Pediatric 难治性儿科
Encyclopedia 百科全书